Journal profile · Infectious Diseases
Transplant Infectious Disease
ISSN 1398-2273 · eISSN 1399-3062 · Wiley-Blackwell Publishing Ltd · UNITED STATES · Quarterly · Founded 1999
Transplant Infectious Disease: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.41; hybrid open access; APC about USD 3,920; median 71 days to acceptance (80 articles, last 24 months); community-reported acceptance: easy; 193 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Transplant Infectious Disease is published by Wiley-Blackwell Publishing Ltd and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cytomegalovirus and herpesvirus research, Antifungal resistance and susceptibility and Fungal Infections and Studies, together about 31.4% of its articles. Its main subfields are Epidemiology. (generated from OpenAlex topic counts and CAS ranking data)
Transplant Infectious Disease is aimed at disseminating the latest information relevant to the infectious disease complications of all immunocompromised patients including adult and pediatric patients with primary immunodeficencies, solid organ transplants, hematologic malignancies and solid tumors, recipients of cellular therapeutics including but not limited to hematopoietic cell transplantation, and other patients receiving chronic immunosuppressive therapy . As exemplified by the international editorial board, we seek articles from all regions of the world to highlight variabilities in the field as influenced by local practices and endemic risks closely related to geography. Only through the sharing of knowledge from experts globally will we be best able to care for patients who, thanks to advances in transplantation, cancer medicine and cellular therapeutics, are able to travel the world and live a more normal life, with a broader range of exposures. The journal also seeks to serve as the global hub for all critical research about infections in patients with other immunocompromised conditions. It further seeks to provide a forum for trainees, junior faculty as well as more seasoned clinician-scientists to share their observations, perspectives and findings during the course of patient care and scientific investigations. Transplant Infectious Disease includes invited state-of-the-art review articles on important subjects, the results of clinical and basic science investigation, a clinical-pathologic conference and correspondences from clinicians about uniquely educational cases. These important papers may be contextualized by leaders in the field to highlight gaps still present in our understanding of the field of immunocompromised host infectious diseases. Subjects covered include basic science and clinical research on specific infections, the epidemiology of important infections, the interaction among immunosuppression and infection exposure, the diagnosis of specific infection, pathogenesis, clinical management and prevention.This journal is meant to serve the needs of all clinicians and scientists involved in the study and care of infections in immunocompromised adult and pediatric patients.
From the journal's Aims & Scope
Research area (LetPub): Infectious Diseases
Editor-in-chief Michael G. IsonPublisher website
Editorial board by country: none in mainland China; most named United States 60, Australia 15, Canada 8, Spain 6, Switzerland 6 (123 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cytomegalovirus and herpesvirus researchMedicine15.4%
- Antifungal resistance and susceptibilityMedicine8.6%
- Fungal Infections and StudiesMedicine7.4%
- Renal Transplantation Outcomes and TreatmentsMedicine7.1%
- Polyomavirus and related diseasesMedicine5.8%
- Pneumocystis jirovecii pneumonia detection and treatmentMedicine5.1%
- Transplantation: Methods and OutcomesMedicine5%
- Herpesvirus Infections and TreatmentsMedicine4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Immunology | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
| Minor | Transplantation | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Immunology | Zone 3 |
| Minor | Infectious Diseases | Zone 4 |
| Minor | Transplantation | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Immunology | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
| Minor | Transplantation | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbaseCASCAB AbstractsCurrent ContentsPublisher website
Other: EBSCO, ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.41LetPub ·
- Impact factor (publisher)
- 2.5Publisher website ·
- Impact factor (publisher) 2025
- 2.5Publisher website ·
- CiteScore 2026-06
- 5LetPub ·
- CiteScore (publisher)
- 5Publisher website ·
- CiteScore (publisher) 2025
- 5Publisher website ·
- SJR 2026-06
- 0.8LetPub ·
- SNIP 2026-06
- 0.75LetPub ·
- h-index
- 60LetPub ·
- h-index
- 89OpenAlex ·
- i10-index
- 1,871OpenAlex ·
- 2-year mean citedness
- 1.73OpenAlex ·
- Self-citation rate
- 12%LetPub ·
- Share of gold OA articles
- 40.2%LetPub ·
Volume
- Articles per year
- 118LetPub ·
- Articles per year (publisher) 2025
- 162Publisher website ·
- Downloads per year (publisher) 2025
- 304,787Publisher website ·
Articles by year OpenAlex count · 3,913 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 169 | 121 | 31 |
| 2025 | 193 | 104 | 290 |
| 2024 | 216 | 118 | 679 |
| 2023 | 227 | 134 | 1,362 |
| 2022 | 221 | 94 | 1,645 |
| 2021 | 236 | 94 | 2,576 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
71 daysMedian, submission to acceptance · P25–P75 33 days – 112 days
- Acceptance to online
- median 15 days (80 articles)
- Submission to online
- median 98 days
- Sample
- 80 articles with submission and acceptance dates (408 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Acceptance rate (publisher)
- 40%Publisher website ·
- Acceptance rate (publisher) 2025
- 40%Publisher website ·
- Submission to first decision
- 5 daysPublisher website ·
- Submission to first decision 2025
- 5 daysPublisher website ·
- Submission to acceptance 2025
- 56 daysPublisher website ·
- Acceptance to publication 2025
- 15 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,920 / EUR 3,240 / GBP 2,670 | — | — | |
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted14, with length limits
- brief communicationManuscript Type Main Text Word Limit Abstract Word Limit References Tables/Figures Notes Original Article 4000 250 structured None 4 Visual Abstract Required Br…main text ≤ 2,000 words
- brief communicationsBrief Communications 2000 250 structured 30 2 Visual Abstract Requiredmain text ≤ 2,000 words
- clinical correspondencesClinical Correspondences 1200 None 15 2 Drafted as letter to editormain text ≤ 1,200 words
- clinicopathologic case conferenceClinicopathologic Case Conference 6000 None No Limit No Limit Invited onlymain text ≤ 6,000 words
- editorialManuscript Type Main Text Word Limit Abstract Word Limit References Tables/Figures Notes Original Article 4000 250 structured None 4 Visual Abstract Required Br…main text ≤ 1,200 words
- images in tidImages in TID 800 None 10 2main text ≤ 800 words
- letterManuscript Type Main Text Word Limit Abstract Word Limit References Tables/Figures Notes Original Article 4000 250 structured None 4 Visual Abstract Required Br…Length not stated
- letter to the editorManuscript Type Main Text Word Limit Abstract Word Limit References Tables/Figures Notes Original Article 4000 250 structured None 4 Visual Abstract Required Br…main text ≤ 500 words
- meeting reportsMeeting Reports 8000 None No Limit No Limitmain text ≤ 8,000 words
- original articleOriginal Article (Maximum 4000 Word Text, 250 Word Structured Abstract, no reference limit, no more than 4 tables or figures; Visual Abstract is required). Repo…main text ≤ 4,000 words
- patient perspectivesPatient Perspectives No Limit None No Limit No Limit Invited onlyLength not stated
- perspectiveManuscript Type Main Text Word Limit Abstract Word Limit References Tables/Figures Notes Original Article 4000 250 structured None 4 Visual Abstract Required Br…main text ≤ 6,000 words
- perspective - experience from the fieldPerspective - Experience from the field 6000 None No Limit No Limit Invited onlymain text ≤ 6,000 words
- review articleManuscript Type Main Text Word Limit Abstract Word Limit References Tables/Figures Notes Original Article 4000 250 structured None 4 Visual Abstract Required Br…main text ≤ 6,000 words
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, Peer review, Plagiarism, Trial registration / reporting guidelines
- Authorship Authorship
Please refer to the 'Editorial Policies and Ethical Considerations' section for details on author listing eligibility.
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest Statement
Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the 'Editorial Policies and Ethical Considerations' section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.
Source ↗Publisher website ·- Data availability Data Sharing and Data Accessibility
Data sharing expected in public repository Model summary
The journal expects that data supporting the results in the paper will be archived in an appropriate public repository. Whenever possible the scripts and other artefacts used to generate the analyses presented in the paper should also be publicly archived. Exceptions may be granted at the discretion of the editors for sensitive information such as human subject data or the location of endangered s…
Source ↗Publisher website ·- Publication ethics Publication Ethics
Member of COPE (Committee on Publication Ethics) Model summary
This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley’s Top 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found here.
Source ↗Publisher website ·- Peer review Peer Review and Acceptance
The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Except where otherwise stated, manuscripts are peer reviewed. Papers will only be sent to review if the Editors determine that the paper meets the appropriate quality and relevance requirements.
Source ↗Publisher website ·- Plagiarism
Uses iThenticate CrossCheck for plagiarism detection Model summary
Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the abstract. If the trial is not registered, or was registered retrospectivel…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Quarterly
- Founded
- 1999
- ISSN
- 1398-2273
- Electronic ISSN
- 1399-3062
- Latest issue on the website
- Volume 28, Issue 4 (August 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Transplant Infectious Disease
What CAS zone is Transplant Infectious Disease in?
In the 2025 upgraded edition of the CAS Journal Ranking, Transplant Infectious Disease is in Zone 4 of Medicine, and in Zone 4 of the minor category Immunology / Infectious Diseases / Transplantation. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Transplant Infectious Disease?
The latest impact factor listed by LetPub is 2.41; CiteScore 5, h-index 89.
How long does peer review take at Transplant Infectious Disease?
Based on the dates recorded on 80 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 71 days (interquartile range 33–112 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Easy”; the journal's website gives an acceptance rate of 40% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Transplant Infectious Disease based?
Of the 123 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (60), Australia (15) and Canada (8). Counted from the institutions listed on the board page; for reference only.
Which databases index Transplant Infectious Disease?
According to LetPub and DOAJ records, Transplant Infectious Disease is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PubMed, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Transplant Infectious Disease open access, and what is the APC?
Transplant Infectious Disease is a hybrid journal. For open-access publication: APC about USD 3,920.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .